293 related articles for article (PubMed ID: 19250848)
1. Splenic marginal zone lymphoma: Clinical clustering of immunoglobulin heavy chain repertoires.
Arcaini L; Zibellini S; Passamonti F; Rattotti S; Lucioni M; Invernizzi R; Merli M; Rizzi S; Boveri E; Rumi E; Astori C; Picone C; Varettoni M; Pascutto C; Paulli M; Lazzarino M
Blood Cells Mol Dis; 2009; 42(3):286-91. PubMed ID: 19250848
[TBL] [Abstract][Full Text] [Related]
2. Splenic marginal-zone lymphoma: one or more entities? A histologic, immunohistochemical, and molecular study of 42 cases.
Papadaki T; Stamatopoulos K; Belessi C; Pouliou E; Parasi A; Douka V; Laoutaris N; Fassas A; Anagnostopoulos A; Anagnostou D
Am J Surg Pathol; 2007 Mar; 31(3):438-46. PubMed ID: 17325486
[TBL] [Abstract][Full Text] [Related]
3. Immunoglobulin heavy chain variable region gene usage and mutational status of the leukemic B cells in Iranian patients with chronic lymphocytic leukemia.
Hojjat-Farsangi M; Jeddi-Tehrani M; Razavi SM; Sharifian RA; Mellstedt H; Shokri F; Rabbani H
Cancer Sci; 2009 Dec; 100(12):2346-53. PubMed ID: 19824994
[TBL] [Abstract][Full Text] [Related]
4. Over 30% of patients with splenic marginal zone lymphoma express the same immunoglobulin heavy variable gene: ontogenetic implications.
Bikos V; Darzentas N; Hadzidimitriou A; Davis Z; Hockley S; Traverse-Glehen A; Algara P; Santoro A; Gonzalez D; Mollejo M; Dagklis A; Gangemi F; Bosler DS; Bourikas G; Anagnostopoulos A; Tsaftaris A; Iannitto E; Ponzoni M; Felman P; Berger F; Belessi C; Ghia P; Papadaki T; Dogan A; Degano M; Matutes E; Piris MA; Oscier D; Stamatopoulos K
Leukemia; 2012 Jul; 26(7):1638-46. PubMed ID: 22222599
[TBL] [Abstract][Full Text] [Related]
5. [Development of IgHV family specific nucleic acid vaccine against lymphoma by construction of fusion gene of immunoglobulin heavy chain variable region and cytokine].
Liu H; Zhu P; Lin NJ; Zhang Y; Bu DF; Wang YJ; Wang YQ; Yang Y
Zhonghua Yi Xue Za Zhi; 2004 Jan; 84(1):48-53. PubMed ID: 14990159
[TBL] [Abstract][Full Text] [Related]
6. IGHV3-21 gene expression in patients with B-cell chronic lymphocytic leukemia in Ukraine.
Abramenko I; Bilous N; Kryachok I; Filonenko I; Pilipenko G; Chumak A; Bazyka D; Bebeshko V
Exp Oncol; 2007 Sep; 29(3):226-30. PubMed ID: 18004251
[TBL] [Abstract][Full Text] [Related]
7. IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenström macroglobulinemia/lymphoplasmacytic lymphomas.
Gachard N; Parrens M; Soubeyran I; Petit B; Marfak A; Rizzo D; Devesa M; Delage-Corre M; Coste V; Laforêt MP; de Mascarel A; Merlio JP; Bouabdhalla K; Milpied N; Soubeyran P; Schmitt A; Bordessoule D; Cogné M; Feuillard J
Leukemia; 2013 Jan; 27(1):183-9. PubMed ID: 22944768
[TBL] [Abstract][Full Text] [Related]
8. An Immunogenetic Signature of Ongoing Antigen Interactions in Splenic Marginal Zone Lymphoma Expressing IGHV1-2*04 Receptors.
Bikos V; Karypidou M; Stalika E; Baliakas P; Xochelli A; Sutton LA; Papadopoulos G; Agathangelidis A; Papadopoulou E; Davis Z; Algara P; Kanellis G; Traverse-Glehen A; Mollejo M; Anagnostopoulos A; Ponzoni M; Gonzalez D; Pospisilova S; Matutes E; Piris MA; Papadaki T; Ghia P; Rosenquist R; Oscier D; Darzentas N; Tzovaras D; Belessi C; Hadzidimitriou A; Stamatopoulos K
Clin Cancer Res; 2016 Apr; 22(8):2032-40. PubMed ID: 26647217
[TBL] [Abstract][Full Text] [Related]
9. Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study.
Bomben R; Dal Bo M; Capello D; Forconi F; Maffei R; Laurenti L; Rossi D; Del Principe MI; Zucchetto A; Bertoni F; Rossi FM; Bulian P; Cattarossi I; Ilariucci F; Sozzi E; Spina V; Zucca E; Degan M; Lauria F; Del Poeta G; Efremov DG; Marasca R; Gaidano G; Gattei V
Br J Haematol; 2009 Feb; 144(4):492-506. PubMed ID: 19036101
[TBL] [Abstract][Full Text] [Related]
10. Immunoglobulin heavy- and light-chain repertoire in splenic marginal zone lymphoma.
Stamatopoulos K; Belessi C; Papadaki T; Kalagiakou E; Stavroyianni N; Douka V; Afendaki S; Saloum R; Parasi A; Anagnostou D; Laoutaris N; Fassas A; Anagnostopoulos A
Mol Med; 2004; 10(7-12):89-95. PubMed ID: 15706403
[TBL] [Abstract][Full Text] [Related]
11. Immunoarchitectural patterns in splenic marginal zone lymphoma: correlations with chromosomal aberrations, IGHV mutations, and survival. A study of 76 cases.
Traverse-Glehen A; Bachy E; Baseggio L; Callet-Bauchu E; Gazzo S; Verney A; Hayette S; Jallades L; Ffrench M; Salles G; Coiffier B; Felman P; Berger F
Histopathology; 2013 May; 62(6):876-93. PubMed ID: 23611359
[TBL] [Abstract][Full Text] [Related]
12. Immunoglobulin gene rearrangements and mutational status in argentinian patients with chronic lymphocytic leukemia.
Stanganelli C; Travella A; Bezares R; Slavutsky I
Clin Lymphoma Myeloma Leuk; 2013 Aug; 13(4):447-457.e2. PubMed ID: 23665144
[TBL] [Abstract][Full Text] [Related]
13. IGHV3-21 gene usage is associated with high TCL1 expression in chronic lymphocytic leukemia.
Mansouri MR; Sevov M; Aleskog A; Jondal M; Merup M; Sundström C; Osorio L; Rosenquist R
Eur J Haematol; 2010 Feb; 84(2):109-16. PubMed ID: 19889012
[TBL] [Abstract][Full Text] [Related]
14. High-resolution genome-wide array comparative genomic hybridization in splenic marginal zone B-cell lymphoma.
Novara F; Arcaini L; Merli M; Passamonti F; Zibellini S; Rizzi S; Rattotti S; Rumi E; Pascutto C; Vetro A; Astori C; Boveri E; Lucioni M; Paulli M; Zuffardi O; Lazzarino M
Hum Pathol; 2009 Nov; 40(11):1628-37. PubMed ID: 19647853
[TBL] [Abstract][Full Text] [Related]
15. Analysis of VH genes in marginal zone lymphoma reveals marked heterogeneity between splenic and nodal tumors and suggests the existence of clonal selection.
Traverse-Glehen A; Davi F; Ben Simon E; Callet-Bauchu E; Felman P; Baseggio L; Gazzo S; Thieblemont C; Charlot C; Coiffier B; Berger F; Salles G
Haematologica; 2005 Apr; 90(4):470-8. PubMed ID: 15820942
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of immunoglobulin gene rearrangements in diffuse large B-cell lymphoma: antigen-driven origin and IGHV4-34 as a particular subgroup of the non-GCB subtype.
Sebastián E; Alcoceba M; Balanzategui A; Marín L; Montes-Moreno S; Flores T; González D; Sarasquete ME; Chillón MC; Puig N; Corral R; Pardal E; Martín A; González-Barca E; Caballero MD; San Miguel JF; García-Sanz R; González M
Am J Pathol; 2012 Nov; 181(5):1879-88. PubMed ID: 22982190
[TBL] [Abstract][Full Text] [Related]
17. High-throughput sequencing analysis of the chromosome 7q32 deletion reveals IRF5 as a potential tumour suppressor in splenic marginal-zone lymphoma.
Fresquet V; Robles EF; Parker A; Martinez-Useros J; Mena M; Malumbres R; Agirre X; Catarino S; Arteta D; Osaba L; Mollejo M; Hernandez-Rivas JM; Calasanz MJ; Daibata M; Dyer MJ; Prosper F; Vizcarra E; Piris MÁ; Oscier D; Martinez-Climent JA
Br J Haematol; 2012 Sep; 158(6):712-26. PubMed ID: 22816737
[TBL] [Abstract][Full Text] [Related]
18. Clonally related splenic marginal zone lymphoma and Hodgkin lymphoma with unmutated V gene rearrangements and a 15-yr time gap between diagnoses.
Rosenquist R; Roos G; Erlanson M; Küppers R; Bräuninger A; Hansmann ML
Eur J Haematol; 2004 Sep; 73(3):210-4. PubMed ID: 15287919
[TBL] [Abstract][Full Text] [Related]
19. Classical Hodgkin lymphoma concurrently evolving in a patient with marginal zone B-cell lymphoma of the spleen.
Harada S; Kalla H; Balasubramanian M; Brodsky I; Gladstone D; Hou JS
Ann Diagn Pathol; 2008 Jun; 12(3):212-6. PubMed ID: 18486899
[TBL] [Abstract][Full Text] [Related]
20. Mutation analysis of IgVH genes in splenic marginal zone lymphomas: correlation with clinical characteristics and outcome.
Kalpadakis C; Pangalis GA; Dimitriadou E; Angelopoulou MK; Siakantaris MP; Kyrtsonis MC; Ximeris M; Tzenou T; Sahanas S; Yiakoumis X; Papadaki EA; Panayiotidis P; Vassilakopoulos T
Anticancer Res; 2009 May; 29(5):1811-6. PubMed ID: 19443409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
